Cellio Therapeutics Inc
1 clinical trials · Sponsor
◉ Watch Cellio Therapeutics Inc
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of C.001 in Retinal Degeneration (NCT07594236) | Cellio Therapeutics Inc | 2026-04-07 |
Track Cellio Therapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.